Literature DB >> 3542450

Dissociation of insulin absorption and blood flow during massage of a subcutaneous injection site.

B Linde.   

Abstract

Nine healthy volunteers with normal body weights were injected subcutaneously with 125I-labeled soluble human insulin (10 U) in one thigh and 133Xe in the contralateral thigh for the measurement of subcutaneous blood flow on 2 consecutive mornings. On one of the days, standardized massage of both injection sites was performed for 30 min starting 30 min after insulin injection. Serum insulin and plasma glucose were determined intermittently before, during, and after massage, and elimination of radioactivities was monitored continuously by external detectors. During massage, the first-order elimination rate constants of 125I increased approximately sixfold compared with the rise during control (0.19 +/- 0.04 to 0.88 +/- 0.15%/min during the last 15 min of the massage vs. 0.21 +/- 0.03 to 0.32 +/- 0.03%/min during control). Serum insulin increased from 13.8 +/- 1.8 mU/L before massage to a maximal value of 56.4 +/- 8.7 mU/L 10 min after massage (vs. 15.3 +/- 3.0 and 19.7 +/- 2.2 mU/L during control). Plasma glucose fell significantly faster on the massage day, from 10 min after massage onward. No significant alteration in the subcutaneous blood flow was found during or after massage. The results suggest that the pronounced enhancement of insulin absorption induced by massage of the injection site is mainly not blood flow mediated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542450     DOI: 10.2337/diacare.9.6.570

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

1.  Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.

Authors:  S A Charman; D N McLennan; G A Edwards; C J Porter
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 2.  Pharmacokinetic considerations of new insulin formulations and routes of administration.

Authors:  A Hoffman; E Ziv
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 3.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 4.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

5.  Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

Authors:  J P Vora; D R Owens; J Dolben; J A Atiea; J D Dean; S Kang; A Burch; J Brange
Journal:  BMJ       Date:  1988-11-12

6.  Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.

Authors:  F S Nielsen; L N Jørgensen; M Ipsen; A I Voldsgaard; H H Parving
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

Review 7.  Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability.

Authors:  A K J Gradel; T Porsgaard; J Lykkesfeldt; T Seested; S Gram-Nielsen; N R Kristensen; H H F Refsgaard
Journal:  J Diabetes Res       Date:  2018-07-04       Impact factor: 4.011

8.  Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet-induced obesity.

Authors:  A K J Gradel; T Porsgaard; P B Brockhoff; T Seested; J Lykkesfeldt; H H F Refsgaard
Journal:  Obes Sci Pract       Date:  2019-03-18

Review 9.  Factors Influencing Insulin Absorption Around Exercise in Type 1 Diabetes.

Authors:  Jason P Pitt; Olivia M McCarthy; Thomas Hoeg-Jensen; Benjamin M Wellman; Richard M Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-21       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.